AGEN reverse split pumpA reverse split pump in the small cap stock market refers to a situation where a company, typically with a low stock price, undergoes a reverse stock split in order to artificially inflate its stock price. Here's how it typically works:
Low Stock Price: Small cap stocks often have low prices per sh
−13.88USD
−245.76 MUSD
156.31 MUSD
20.95 M
About Agenus Inc.
Sector
Industry
CEO
Garo H. Armen
Website
Headquarters
Lexington
Employees (FY)
389
Founded
1994
ISIN
US00847G8042
FIGI
BBG000C8SWQ9
Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.
AGEN - LONGAGEN, a leader in discovering and developing novel immunological agents to treat various cancers, today announced that Dr. Garo Armen, Chairman and CEO, will participate in a fireside chat and investor one-on-ones at the upcoming Leerink Global Biopharma Conference on March 11th - 13th in Miami Beac
AGEN | Agenus Inc. Healthcare | Biotechnology | USA | NASDAQ
📈 Technical Chart Patterns & Trend Analysis 📉
Identifying potential trading opportunities based on trend analysis:
After forming Bullish divergence the price charts signals a potential trend reversal, indicating a shift from a downtrend to a possible uptrend.
AGENUS Stock Chart Fibonacci Analysis 071023 Trading Idea
1) Find a FIBO slingshot
2) Check FIBO 61.80% level
3) Entry Point > 1.7/61.80%
Chart time frame : B
A) 15 min(1W-3M)
B) 1 hr(3M-6M)
C) 4 hr(6M-1year)
D) 1 day(1-3years)
Stock progress : A
A) Keep rising over 61.80% resistance
B) 61.80% resistance
C) Hit the bottom
D) Hit the top
AGENUS going back inAgenus NASDAQ:AGEN is a stock that I have not followed since they were forced (unfairly) by the FDA to pull their NDA for balstilimab. However recently price action has started to look favourable and this is in conjuction with ASCO where the company is presenting clinical data from 2 trials.
Gap Fill + Great earnings reportThe earnings report is expected to be good and therefore i think there will at least be a gap fill up to 5.
Looking at the macd it also looks like we are gonna have a green crossover to the upwards movement. I wouldsay bullish.
I could be completely wrong and this should be taken with a grain of s
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of AGEN is 5.40 USD — it has decreased by 14.29% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Agenus Inc. stocks are traded under the ticker AGEN.
Agenus Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
AGEN stock is 21.19% volatile and has beta coefficient of 1.58. Check out the list of the most volatile stocks — is Agenus Inc. there?
One year price forecast for Agenus Inc. has a max estimate of 160.00 USD and a min estimate of 35.00 USD.
AGEN earnings for the last quarter are −3.20 USD whereas the estimation was −3.90 USD which accounts for 17.98% surprise. Estimated earnings for the next quarter are −1.07 USD. See more details about Agenus Inc. earnings.
Agenus Inc. revenue for the last quarter amounts to 24.31 M USD despite the estimated figure of 24.33 M USD. In the next quarter revenue is expected to reach 47.05 M USD.
Yes, you can track Agenus Inc. financials in yearly and quarterly reports right on TradingView.
AGEN stock has fallen by 42.55% compared to the previous week, the month change is a 52.61% fall, over the last year Agenus Inc. has showed a 84.57% decrease.
AGEN net income for the last quarter is −46.29 M USD, while the quarter before that showed −62.20 M USD of net income which accounts for 25.58% change. Track more Agenus Inc. financial stats to get the full picture.
Today Agenus Inc. has the market capitalization of 113.11 M, it has decreased by 9.08% over the last week.
No, AGEN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, AGEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Agenus Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 389.00 employees. See our rating of the largest employees — is Agenus Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Agenus Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Agenus Inc. stock shows the strong sell signal. See more of Agenus Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Agenus Inc. future price: according to them, AGEN price has a max estimate of 160.00 USD and a min estimate of 35.00 USD. Read a more detailed Agenus Inc. forecast: see what analysts think of Agenus Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Agenus Inc. EBITDA is −146.52 M USD, and current EBITDA margin is −93.73%. See more stats in Agenus Inc. financial statements.